Literature DB >> 27981374

[On the legalization debate of non-medical cannabis consumption : Position paper of the German Association for Psychiatry, Psychotherapy and Psychosomatics].

U Havemann-Reinecke1,2, E Hoch3,4, U W Preuss5,4, F Kiefer6,4, A Batra7,4, G Gerlinger4, I Hauth8,4.   

Abstract

Calls are increasing for the legalization of cannabis. Some legal experts, various politicians, political parties and associations are demanding a change in drug policy. The legalization debate is lively and receiving wide coverage in the media. The German Association for Psychiatry, Psychotherapy and Psychosomatics (DGPPN) comments on the most important questions from a medical scientific perspective: can cannabis consumption trigger mental illnesses, what consequences would legalization have for the healthcare system and where is more research needed?

Keywords:  Abuse; Cannabis; Comorbidity; Dependence; Legalization

Mesh：

Substances：

Year:  2017        PMID： 27981374     DOI： 10.1007/s00115-016-0248-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


  32 in total

1.  Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice.

Authors:  Magdalena M Brzózka; André Fischer; Peter Falkai; Ursula Havemann-Reinecke
Journal:  Behav Brain Res       Date:  2010-11-09       Impact factor: 3.332

2.  Genetic predisposition to schizophrenia associated with increased use of cannabis.

Authors:  R A Power; K J H Verweij; M Zuhair; G W Montgomery; A K Henders; A C Heath; P A F Madden; S E Medland; N R Wray; N G Martin
Journal:  Mol Psychiatry       Date:  2014-06-24       Impact factor: 15.992

Review 3.  Cannabis Smoking in 2015: A Concern for Lung Health?

Authors:  Jason R Biehl; Ellen L Burnham
Journal:  Chest       Date:  2015-09       Impact factor: 9.410

4.  Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.

Authors:  Katelijne van Emmerik-van Oortmerssen; Geurt van de Glind; Maarten W J Koeter; Steve Allsop; Marc Auriacombe; Csaba Barta; Eli Torild H Bu; Yuliya Burren; Pieter-Jan Carpentier; Susan Carruthers; Miguel Casas; Zsolt Demetrovics; Geert Dom; Stephen V Faraone; Melina Fatseas; Johan Franck; Brian Johnson; Máté Kapitány-Fövény; Sharlene Kaye; Maija Konstenius; Frances R Levin; Franz Moggi; Merete Møller; J Antoni Ramos-Quiroga; Arild Schillinger; Arvid Skutle; Sofie Verspreet; Wim van den Brink; Robert A Schoevers
Journal:  Addiction       Date:  2013-11-20       Impact factor: 6.526

5.  [Reports].

Authors:  Rainer Thomasius; Martin Holtmann; Peter Melchers; Edelhard Thoms; Martin Jung; Gisela Schimansky; Thomas Kroemer
Journal:  Z Kinder Jugendpsychiatr Psychother       Date:  2016

6.  Cannabinoid receptor type I modulates alcohol-induced liver fibrosis.

Authors:  Eleonora Patsenker; Matthias Stoll; Gunda Millonig; Abbas Agaimy; Till Wissniowski; Vreni Schneider; Sebastian Mueller; Rudolf Brenneisen; Helmut K Seitz; Matthias Ocker; Felix Stickel
Journal:  Mol Med       Date:  2011-08-19       Impact factor: 6.354

7.  Stress- and cue-elicited craving and reactivity in marijuana-dependent individuals.

Authors:  Aimee L McRae-Clark; Rickey E Carter; Kimber L Price; Nathaniel L Baker; Suzanne Thomas; Michael E Saladin; Kathleen Giarla; Katherine Nicholas; Kathleen T Brady
Journal:  Psychopharmacology (Berl)       Date:  2011-06-28       Impact factor: 4.530

8.  Combined effects of marijuana and nicotine on memory performance and hippocampal volume.

Authors:  Francesca M Filbey; Tim McQueeny; Shrinath Kadamangudi; Collette Bice; Ariel Ketcherside
Journal:  Behav Brain Res       Date:  2015-07-14       Impact factor: 3.332

9.  A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder.

Authors:  Aimee L McRae-Clark; Rickey E Carter; Therese K Killeen; Matthew J Carpenter; Kathleen G White; Kathleen T Brady
Journal:  Am J Addict       Date:  2010-09-21

Review 10.  The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders.

Authors:  Courtney A Zulauf; Susan E Sprich; Steven A Safren; Timothy E Wilens
Journal:  Curr Psychiatry Rep       Date:  2014-03       Impact factor: 5.285
View more
  1 in total

1.  [Medicinal cannabis and cannabis-based medication: an appeal to physicians, journalists, health insurances, and politicians for their responsible handling].

Authors:  Winfried Häuser; Eva Hoch; Frank Petzke; Rainer Thomasius; Lukas Radbruch; Anil Batra; Claudia Sommer; Ursula Havemann-Reinecke
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.